MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer

Carcinogenesis

Volumn 33, Issue 5, 2012, Pages 1046-1054

  Lu, Yan ^a   Govindan, Ramaswamy ^b   Wang, Liang ^c   Liu, Peng Yuan ^a   Goodgame, Boone ^b   Wen, Weidong ^d   Sezhiyan, Ananth ^b   Pfeifer, John ^b   Li, Ya Fei ^c   Hua, Xing ^a   Wang, Yian ^d   Yang, Ping ^c   You, Ming ^a,d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b USA   (United States)

^c MAYO CLINIC   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

EID: 84860466755     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs100     Document Type: Article

References (34)

1. Goodgame, B. et al. (2008) A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer. Am. J. Clin. Oncol., 31, 22-28.
2. Subramanian, J. et al. (2010) Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J. Natl Cancer Inst., 102, 464-474.
3. Calin, G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
4. Johnson, C.D. et al. (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res., 67, 7713-7722.
5. Yanaihara, N. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198.
6. Raponi, M. et al. (2009) MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res., 69, 5776-5783.
7. Landi, M.T. et al. (2010) MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin. Cancer Res., 16, 430-441.
8. Patnaik, S.K. et al. (2010) Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res., 70, 36-45.
9. Zhang, X. et al. (2008) An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J. Mol. Diagn., 10, 513-519.
10. Pounds, S. et al. (2006) Robust estimation of the false discovery rate. Bioinformatics, 22, 1979-1987.
11. Li, H. et al. (2004) Partial Cox regression analysis for high-dimensional microarray gene expression data. Bioinformatics, 20 (suppl. 1), i208-i215.
12. Lebanony, D. et al. (2009) Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J. Clin. Oncol., 27, 2030-2037.
13. Fassina, A. et al. (2011) Classification of non-small cell lung carcinoma in trans-thoracic needle specimens using microRNA expression profiling. Chest, 140, 1305-1311.
14. Liu, X. et al. (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J. Clin. Invest., 120, 1298-1309.
15. Bommer, G.T. et al. (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol., 17, 1298-1307.
16. Chang, T.C. et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 26, 745-752.
17. Corney, D.C. et al. (2007) MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res., 67, 8433-8438.
18. He, L. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
19. Johnson, S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
20. Shedden, K. et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med., 14, 822-827
21. Lu, Y. et al. (2006) A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med., 3, e467.
22. Guo, L. et al. (2006) Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin. Cancer Res., 12, 3344-3354.
23. Chen, G. et al. (2003) Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl Acad. Sci. USA, 100, 13537-13542.
24. Shah, L. et al. (2004) Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma. Cancer, 101, 1632-1638.
25. Larsen, J.E. et al. (2007) Expression profiling defines a recurrence signature in lung squamous cell carcinoma. Carcinogenesis, 28, 760-766.
26. Larsen, J.E. et al. (2007) Gene expression signature predicts recurrence in lung adenocarcinoma. Clin. Cancer Res., 13, 2946-2954.
27. Sun, Z. et al. (2008) Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival. J. Clin. Oncol., 26, 877-883.
28. Skrzypski, M. et al. (2008) Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin. Cancer Res., 14, 4794-4799.
29. Forbes, S. et al. (2006) Cosmic 2005. Br. J. Cancer, 94, 318-322.
30. Brose, M.S. et al. (2002) BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res., 62, 6997-7000.
31. Sachdeva, M. et al. (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res., 70, 378-387.
32. Rye, P.D. et al. (1996) Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int. J. Cancer, 68, 682-687.
33. Sengupta, S. et al. (2008) MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl Acad. Sci. USA, 105, 5874-5878.
34. Tie, J. et al. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet., 6, e1000879.